Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE
Mon, Jul 2, 2018 2:20pm

Mayo Clinic leads biobanking efforts in support of PSC Research

By Konstantinos N. Lazaridis, M.D., @klazaridis

2018-09-18-Biobanking

 

For more than four decades, the Mayo Clinic Division of Gastroenterology and Hepatology has led the field in clinical and scientific discoveries related to Primary Sclerosing Cholangitis (PSC) and has served as the main referral center for PSC in the United States. As a result, Mayo Clinic is home to the largest PSC biobank in the United States, if not the world. Given the rarity of PSC, the biobank containing biospecimens collected from about 1,500 patients represents a critical resource for translational research studies of the disease.

In the following video, Mayo Clinic hepatologist Konstantinos N. Lazaridis, M.D. explains the importance of this biobank, the effort it took to build it, his team’s immediate and future goals and the privilege of studying such a unique collection of biospecimens.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

We'll include this text in the user's invitation.